Post

Clinical Investigation of Nocturnal Home Hemodialysis Delivery Systems

This guidance addresses IDE applications for clinical investigation of hemodialysis delivery systems intended for Nocturnal Home Hemodialysis (NHHD). NHHD is defined as chronic hemodialysis performed at home while the patient is sleeping, typically at night, up to 7 times per week, for 6-10 hours per treatment, administered by the patient or trained partner. The guidance covers sorbent regenerated dialysate delivery systems, hemodialysis systems and accessories, and high permeability hemodialysis systems when used for NHHD.

  1. Develop comprehensive testing plan covering all required non-clinical testing aspects
  2. Design and validate robust safety features and alarms suitable for home/nocturnal use
  3. Create detailed training program for users and care partners
  4. Develop comprehensive labeling including user manual and patient materials
  5. Establish home environment assessment protocol
  6. Design monitoring protocol including care partner presence requirements
  7. Create water quality and dialysate monitoring procedures if applicable
  8. Implement human factors validation program
  9. Develop detailed investigational plan including in-clinic and home use periods
  10. Establish clear subject selection criteria including home environment suitability

Key Considerations

Clinical testing

  • Study should include in-clinic period followed by home-use period
  • Compare assessments between in-clinic and home use periods
  • Evaluate adverse events, ability to deliver prescribed treatments, and device reliability
  • Care partner must be present throughout dialysis treatment
  • Remote monitoring should not be sole method of patient monitoring

Non-clinical testing

  • Functional testing under standard and worst-case conditions
  • System-level hazard analysis including use errors
  • Electrical safety testing
  • EMC testing at 10 V/m level for home environment
  • Performance testing of remote alarm transmission capabilities
  • Testing of dedicated tubing sets if applicable

Human Factors

  • Validation of patient/user interface considering human factors and ergonomics
  • Non-clinical usability study demonstrating safe device performance by prospective users
  • Training evaluation and assessment of user comprehension
  • Practical tests to assess subject’s understanding

Software

  • Major level of concern documentation required
  • Software validation according to FDA guidance

Labelling

  • Operator’s manual with therapy background, device description, operation instructions
  • Patient labeling in layman’s terms
  • Pre-treatment setup checklist
  • List of alarms and troubleshooting directions
  • Environmental requirements and supplies needed

Biocompatibility

  • Testing for all direct/indirect patient-fluid contacting components
  • Tests appropriate for duration and level of patient contact
  • Alternative leach testing and risk assessment for indirect contact materials

Safety

  • Multiple safety features required (air detection, blood leak detection, etc.)
  • Alarms must be able to awaken sleeping users
  • Fail-safe design features for power failure
  • Disinfection and cleaning capabilities

Other considerations

  • IEC 60601-1: Medical Electrical Equipment – Part 1: General Requirements for Safety
  • IEC 60601-1-2: Medical Electrical Equipment – Part 1-2: General Requirements for Safety; Electromagnetic Compatibility
  • IEC 60601-1-8: Medical electrical equipment Part 1-8: General requirements for safety - Collateral standard: general requirements, tests and guidance for alarm systems
  • ISO 14972: Risk management standard
  • AAMI/ANSI HE74:2001: Human Factors Design Process for Medical Devices
  • AAMI RD62:2001: Water treatment equipment for hemodialysis applications

Original guidance

  • Clinical Investigation of Nocturnal Home Hemodialysis Delivery Systems
  • HTML / PDF
  • Issue date: 2008-04-15
  • Last changed date: 2020-03-20
  • Status: FINAL
  • Official FDA topics: Medical Devices, Investigational Device Exemption (IDE), Premarket
  • ReguVirta summary file ID: c7d8b677a120c3e3490139924aaf78f8
This post is licensed under CC BY 4.0 by the author.